{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T01:57:29Z","timestamp":1791511049296,"version":"4.3.4"},"reference-count":17,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2015,4,1]],"date-time":"2015-04-01T00:00:00Z","timestamp":1427846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,4,1]],"date-time":"2015-04-01T00:00:00Z","timestamp":1427846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100009633","name":"Eunice Kennedy Shriver National Institute of Child Health and Human Development","doi-asserted-by":"publisher","award":["2R24HD047879"],"award-info":[{"award-number":["2R24HD047879"]}],"id":[{"id":"10.13039\/100009633","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","contraceptionjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Contraception"],"published-print":{"date-parts":[[2015,4]]},"DOI":"10.1016\/j.contraception.2015.01.005","type":"journal-article","created":{"date-parts":[[2015,1,13]],"date-time":"2015-01-13T20:55:58Z","timestamp":1421182558000},"page":"269-273","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":62,"title":["Efficacy and safety of medical abortion using mifepristone and buccal misoprostol through 63 days"],"prefix":"10.1016","volume":"91","author":[{"given":"Mary","family":"Gatter","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly","family":"Cleland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah L.","family":"Nucatola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.contraception.2015.01.005_bb0005","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1056\/NEJM199305273282101","article-title":"Early termination of pregnancy with mifepristone (RU-486) and the orally active prostaglandin misoprostol","volume":"328","author":"Peyron","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1016\/j.contraception.2015.01.005_bb0010","first-page":"56","article-title":"Termination of early pregnancy (up to and after 63days of amenorrhea) with mifepristone (RU 486) and increasing doses of misoprostol (vol 40, pg 85, 1995)","volume":"41","author":"Aubeny","year":"1996","journal-title":"Int J Fertil Menopausal Stud"},{"key":"10.1016\/j.contraception.2015.01.005_bb0015","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1056\/NEJM199804303381801","article-title":"Early pregnancy termination with mifepristone and misoprostol in the United States","volume":"338","author":"Spitz","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.contraception.2015.01.005_bb0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0010-7824(98)00150-4","article-title":"Low-dose mifepristone 200 mg and vaginal misoprostol for abortion","volume":"59","author":"Schaff","year":"1999","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2015.01.005_bb0025","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1111\/j.1471-0528.2000.tb13273.x","article-title":"Comparison of two doses of mifepristone in combination with misoprostol for early medical abortion: a randomised trial","volume":"107","author":"World Health Organization Task Force on Post-Ovulatory Methods of Fertility Regulation","year":"2000","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.contraception.2015.01.005_bb0030","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1001\/jama.284.15.1948","article-title":"Vaginal misoprostol administered 1, 2, or 3 days after mifepristone for early medical abortion\u2014a randomized trial","volume":"284","author":"Schaff","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.contraception.2015.01.005_bb0035","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0010-7824(01)00229-3","article-title":"Randomized trial of oral versus vaginal misoprostol at one day after mifepristone for early medical abortion","volume":"64","author":"Schaff","year":"2001","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2015.01.005_bb0040","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1097\/AOG.0b013e31818d8eb4","article-title":"Two distinct oral routes of misoprostol in mifepristone medical abortion: a randomized controlled trial","volume":"112","author":"Winikoff","year":"2008","journal-title":"Obstetrics & Gynecology"},{"key":"10.1016\/j.contraception.2015.01.005_bb0045","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1097\/AOG.0b013e31826c315f","article-title":"Extending outpatient medical abortion services through 70 days of gestational age","volume":"120","author":"Winikoff","year":"2012","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.contraception.2015.01.005_bb0050","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.contraception.2009.03.010","article-title":"Effectiveness of medical abortion with mifepristone and buccal misoprostol through 59 gestational days","volume":"80","author":"Fjerstad","year":"2009","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2015.01.005_bb0055","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1097\/AOG.0b013e3182755763","article-title":"Significant adverse events and outcomes after medical abortion","volume":"121","author":"Cleland","year":"2013","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.contraception.2015.01.005_bb0060","first-page":"18","article-title":"Medication abortion restrictions burden women and providers\u2014and threaten US trend toward very early abortion","volume":"16","author":"Boonstra","year":"2013","journal-title":"Guttmacher Policy Rev"},{"key":"10.1016\/j.contraception.2015.01.005_bb0065","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.contraception.2011.01.005","article-title":"Infection and extramural delivery with use of digoxin as a feticidal agent","volume":"85","author":"Steward","year":"2012","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2015.01.005_bb0070","doi-asserted-by":"crossref","first-page":"73","DOI":"10.2105\/AJPH.2012.301097","article-title":"Changes in service delivery patterns after introduction of telemedicine provision of medical abortion in Iowa","volume":"103","author":"Grossman","year":"2013","journal-title":"Am J Public Health"},{"key":"10.1016\/j.contraception.2015.01.005_bb0075","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1097\/AOG.0b013e3181c996f3","article-title":"Alternatives to a routine follow-up visit for early medical abortion","volume":"115","author":"Clark","year":"2010","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.contraception.2015.01.005_bb0080","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.contraception.2011.09.007","article-title":"Comparison of medical abortion follow-up with serum human chorionic gonadotropin testing and in-office assessment","volume":"85","author":"Horning","year":"2012","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2015.01.005_bb0085","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1080\/00016340701203632","article-title":"Risk factors for unsuccessful medical abortion with mifepristone and misoprostol","volume":"86","author":"Haimov-Kochman","year":"2007","journal-title":"Acta Obstet Gynecol Scand"}],"container-title":["Contraception"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782415000062?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782415000062?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T20:11:49Z","timestamp":1757880709000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0010782415000062"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4]]},"references-count":17,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,4]]}},"alternative-id":["S0010782415000062"],"URL":"https:\/\/doi.org\/10.1016\/j.contraception.2015.01.005","relation":{},"ISSN":["0010-7824"],"issn-type":[{"value":"0010-7824","type":"print"}],"subject":[],"published":{"date-parts":[[2015,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy and safety of medical abortion using mifepristone and buccal misoprostol through 63 days","name":"articletitle","label":"Article Title"},{"value":"Contraception","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.contraception.2015.01.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}